GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Moss Genomics Inc (XCNQ:MOSS) » Definitions » Additional Paid-In Capital

Moss Genomics (XCNQ:MOSS) Additional Paid-In Capital : C$0.00 Mil(As of Dec. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Moss Genomics Additional Paid-In Capital?



Moss Genomics Additional Paid-In Capital Historical Data

The historical data trend for Moss Genomics's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Moss Genomics Additional Paid-In Capital Chart

Moss Genomics Annual Data
Trend Jun22 Jun23
Additional Paid-In Capital
- -

Moss Genomics Quarterly Data
Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Sep24 Dec24
Additional Paid-In Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Moss Genomics Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)* Shares Outstanding (Diluted Average)

Moss Genomics Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Moss Genomics's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.


Moss Genomics Business Description

Traded in Other Exchanges
Address
1030 West Georgia Street, Suite 908, Vancouver, BC, CAN, V6E 2Y3
Moss Genomics Inc is an emerging consumer genomics company that provides personalized health, anti-aging, and wellness solutions based on genomic, microbiome, and epigenome data. The company aims to eliminate barriers in healthcare by offering accessible, affordable at-home testing along with easy-to-understand actionable results.
Executives
Hunter Jordan Director
Lucas Cahill 10% Security Holder

Moss Genomics Headlines

No Headlines